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Abstract  Coagulase-negative  staphylococci  (CNS)  are  a  common  cause  of  bovine  subclinical
mastitis (SCM).  The  prevalence  of  CNS  species  causing  SCM  identiﬁed  by  genotyping  varies
among countries.  Overall,  the  antimicrobial  resistance  in  this  group  of  organisms  is  increasing
worldwide;  however,  little  information  exists  about  a  CNS  species  resistant  to  antibiotics.  The
aim of  the  present  study  was  to  genotypically  characterize  CNS  at  species  level  and  to  determine
the prevalence  and  antibiotic  resistance  proﬁles  of  CNS  species  isolated  from  bovine  SCM  in  51
dairy herds  located  in  the  central  region  of  the  province  of  Cordoba,  Argentina.  In  this  study,  we
identiﬁed  219  CNS  isolates  at  species  level  by  PCR-restriction  fragment  length  polymorphism  of
the groEL  gene.  Staphylococcus  chromogenes  (46.6%)  and  Staphylococcus  haemolyticus  (32%)
were the  most  prevalent  species.  A  minimum  of  three  different  CNS  species  were  present  in
41.2% of  the  herds.  S.  chromogenes  was  isolated  from  most  of  the  herds  (86.3%),  whereas
ed  from  66.7%  of  them.  The  broth  microdilution  method  was  used
ial  susceptibility.  Resistance  to  a  single  compound  or  two  relatedS. haemolyticus  was  isolat
to test  in  vitro  antimicrob∗ Corresponding author.
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compounds  was  expressed  in  43.8%  of  the  isolates.  S.  chromogenes  and  S.  haemolyticus  showed
a very  high  proportion  of  isolates  resistant  to  penicillin.  Resistance  to  two  or  more  non-related
antimicrobials  was  found  in  30.6%  of  all  CNS.  S.  haemolyticus  exhibited  a  higher  frequency  of
resistance  to  two  or  more  non-related  antimicrobials  than  S.  chromogenes.
© 2016  Asociación  Argentina  de  Microbiología.  Published  by  Elsevier  España,










Prevalencia  y  sensibilidad  a  antibióticos  de  especies  de  estaﬁlococos  coagulasa
negativos  provenientes  de  mastitis  subclínica  en  bovinos  de  tambos  de  la  región
central  de  Argentina
Resumen  Los  estaﬁlococos  coagulasa  negativos  (ECN)  son  una  causa  frecuente  de  mastitis
subclínica (MSC)  en  bovinos.  La  prevalencia  de  especies  de  ECN  causantes  de  MSC  identiﬁcadas
por métodos  genotípicos  varía  entre  países.  La  resistencia  antimicrobiana  en  este  grupo  de
organismos  se  está  incrementando  en  el  mundo;  sin  embargo,  existe  poca  información  acerca
de las  especies  de  ECN  resistentes  a  antibióticos.  Los  objetivos  del  presente  estudio  fueron
caracterizar  genotípicamente  los  ECN  a  nivel  de  especie  y  determinar  la  prevalencia  y
los perﬁles  de  resistencia  a  antibióticos  de  las  especies  de  ECN  aisladas  de  MSC  en  bovinos  de
51 rodeos  situados  en  la  provincia  de  Córdoba,  Argentina.  Mediante  polimorﬁsmos  de  los  frag-
mentos de  restricción  del  gen  groEL  identiﬁcamos  219  aislamientos  de  ECN  a  nivel  de  especie.
Staphylococcus  chromogenes  (46,6%)  y  Staphylococcus  haemolyticus  (32%)  fueron  las  especies
más prevalentes.  Un  mínimo  de  3  especies  diferentes  de  ECN  estuvieron  presentes  en  el  41,2%
de los  tambos.  S.  chromogenes  fue  aislado  en  la  mayoría  de  los  tambos  (86,3%),  mientras  que  S.
haemolyticus  fue  aislado  en  el  66,7%  de  aquellos.  Para  el  análisis  de  sensibilidad  a  los  antimicro-
bianos in  vitro  se  usó  el  método  de  microdilución  en  caldo.  La  resistencia  a  un  único  compuesto
o a  2  compuestos  relacionados  fue  expresada  en  el  43,8%  de  los  aislamientos.  S.  chromogenes  y
S. haemolyticus  mostraron  una  muy  elevada  proporción  de  aislamientos  resistentes  a  penicilina.
La resistencia  a  2  o  más  antimicrobianos  no  relacionados  fue  hallada  en  el  30,6%  de  los  ECN.  S.
haemolyticus  exhibió  una  frecuencia  de  resistencia  a  2  o  más  antimicrobianos  no  relacionados
más elevada  que  S.  chromogenes.
© 2016  Asociación  Argentina  de  Microbiología.  Publicado  por  Elsevier  España,





















Bovine  mastitis  is  one  of  the  most  costly  and  complex  dis-
eases  of  the  dairy  industry3,9.  The  complexity  is  reﬂected
in  the  numerous  causative  pathogens,  the  variety  and  mag-
nitude  of  the  physiological  responses  to  these  pathogens
and  the  variation  in  efﬁcacy  of  control  measures  for  dif-
ferent  causative  organisms4,7,17,18,23,32.  Coagulase-negative
staphylococci  (CNS)  have  been  traditionally  considered
minor  pathogens.  However,  their  importance  has  increased
because  they  have  become  the  most  frequently  isolated
group  of  species  from  bovine  milk  in  many  areas  around  the
world16,29,33.  CNS  usually  cause  subclinical  mastitis  (SCM),
resulting  in  an  increase  in  the  somatic  cell  count  (SCC)
and  a  decrease  in  milk  quality  with  the  resulting  eco-
nomic  losses  that  this  implies30.  The  understanding  and
control  of  CNS  mastitis  are  complicated  by  the  hetero-
geneity  of  this  group  of  bacteria.  So  far,  based  on  Jean
Euzéby’s  List  of  Procaryotic  names  with  Standing  in  Nomen-
clature  (http://www.bacterio.net/s/staphylococcus.html),
the  genus  Staphylococcus  contains  47  species  and  24
subspecies.  Even  though,  the  prevalence  of  CNS  species
p
c
Aaries  among  the  studies;  six  species  have  been  reported
o  be  commonly  involved  in  intramammary  infections
IMI)20,30.  Recently,  it  has  been  found  that  CNS  speci-
tion  based  on  the  biochemical  proﬁle  is  not  accurate
nough  for  bovine  CNS  identiﬁcation26. Hence,  molecu-
ar  methods  have  become  an  important  diagnostic  tool
o  improve  CNS  species  differentiation5,15,39. CNS  tend
o  be  more  resistant  to  antibiotics  than  Staphylococcus
ureus  and  easily  develop  multiresistance2,27,32.  In  addi-
ion,  limited  information  is  available  regarding  differences
n  antimicrobial  susceptibility  among  CNS  species  identi-
ed  by  genotyping27,38.  As  yet,  nothing  has  been  reported
bout  the  prevalence  and  susceptibility  antibiotics  of  CNS
pecies  of  dairy  cows  in  Argentina.  Recently,  a  research
onducted  in  our  laboratory8 showed  that  CNS  represent
he  most  prevalent  bacterial  group  of  minor  pathogens
solated  from  the  subclinical  infection  of  dairy  cows  in
órdoba  province,  Argentina.  The  aim  of  the  present  study
as  to  determine  the  prevalence  and  antibiotic  resistance
roﬁles  of  CNS  species  isolated  from  bovine  subclini-
















































































































pecies  identiﬁcation  of  CNS  isolates  by  PCR-RFLP
nalysis of  a  groEL  gene  sequence
n  this  study,  we  included  219  (49.6%)  CNS  randomly  selected
solates  from  a  total  of  441  isolates  in  pure  cultures  from
omposite  milk  samples  with  a  SCC  ≥200  000  cells/ml  in  a
revious  study8.  The  isolates  were  obtained  from  a  previ-
us  cross-sectional  study  conducted  on  a  sample  randomly
elected  from  51  dairy  farms  located  in  Córdoba  province,
rgentina,  with  a  herd  size  of  around  100  and  250  cows37.
he  intramammary  therapy  of  clinical  cases  was  adminis-
ered  in  96.1%  of  the  herds.  Antibiotics  used  for  dry  cow
herapy  were  applied  to  all  cows  in  58.8%  of  herds  for
t  least  one  year.  Among  the  milking  hygienic  practices,
dder  cleaning  before  milking  was  implemented  in  94.1%
f  herds,  whereas  other  practices  such  as  using  individual
aper  towels  and,  pre-  and  post-test  dipping  were  not  or
ere  less  frequently  applied.  On  average,  45  lactating  cows
n  each  herd  were  sampled  by  the  same  investigator.  In
otal,  2296  composite  milk  samples  were  collected.  A  vol-
me  of  0.01  ml  of  milk  was  streaked  on  trypticase  soy  agar
lates  (Sigma--Aldrich,  USA)  containing  5%  sheep  blood  and
ncubated  at  37 ◦C;  plates  were  examined  for  growth  at  24
nd  48  h.  A  mammary  gland  was  considered  infected  by  CNS
hen  growth  of  ≥500  CFU/ml  of  a  particular  organism  and
nly  one  colony  type  on  the  plate  were  isolated8.  Genomic
NA  was  extracted  from  all  isolates  and  all  type  strains
ccording  to  Aires-de-Sousa  et  al.1.  PCR-RFLP  analysis  of  a
artial  groEL  gene  sequence  was  performed  as  described  by
antos  et  al.25.  The  CNS  isolates  were  genotyped  at  species
evel  as  follows:  (1)  the  presence  of  a  DNA  fragment  (approx-
mately  550  bp)  obtained  by  PCR  of  the  partial  groEL  gene
equence  was  identiﬁed,  (2)  the  banding  patterns  obtained
fter  digestion  by  AluI  restriction  enzyme  of  the  groEL  gene
f  type  strains  were  determined,  (3)  these  patterns  were
ompared  with  the  known  sequences  from  the  NCBI  GenBank
atabase,  using  the  NEB  cutter  program  (version  2.0)36,  (4)
hose  CNS  isolates  with  the  same  pattern  of  reference  or
ype-T  strains  were  assigned  to  a  speciﬁc  species.  To  dif-
erentiate  S.  chromogenes  from  S.  hyicus  and  S.  capitis,
CR  products  ampliﬁed  from  reference  and  type-T  strains
nd/or  IMI  isolates  were  digested  with  HindIII and  PvuII25.
he  following  reference  and  type-T  strains  were  included  in
his  study:  S.  aureus  ATCC  29740,  S.  capitis  subsp.  capitis
TCC  35661,  S.  caprae  ATCC  35538T,  S.  chromogenes  ATCC
3764T,  S.  epidermidis  ATCC  12228,  S.  haemolyticus  ATCC
9970T,  S.  hyicus  ATCC  11249T,  S.  saprophyticus  ATCC  49453,
.  sciuri  subsp.  sciuri  ATCC  29060,  S.  sciuri  subsp.  carnati-
us  ATCC700058T,  S.  simulans  ATCC  11631,  S.  warneri  ATCC
9454,  S.  xylosus  ATCC  29971T.
ntibiotic  susceptibility  testing
he  broth  microdilution  method  was  used  to  carry  out
n  vitro  antimicrobial  susceptibility  testing  according  to
linical  Laboratory  Standards  Institute  guidelines  (CLSI)6
ocument  M31-A3.  Custom-made  microtiter  plate  panels
ere  used  (Trek  Diagnostic  Systems,  Magellan  Biosciences,
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ilution  ranges  tested  for  each  agent  were  as  follows:
enicillin  (0.06--8  g/ml),  oxacillin  (0.25--4  g/ml),  eryth-
omycin  (0.25--4  g/ml),  tetracycline  (2--16  g/ml)  and
lindamycin  (0.5--2  g/ml).  S.  aureus  strain  ATCC  29213  was
ncluded  in  each  assay  as  a  control.  The  minimum  inhibitory
oncentrations  (MICs)  results  were  evaluated  based  on
eterinary  interpretive  criteria  of  the  CLSI6,  with  resis-
ance  breakpoints  of  0.25  g/ml  for  penicillin,  0.5  g/ml  for
xacillin,  1  g/ml  for  erythromycin  and  8  g/ml  for  tetra-
ycline.  Clindamycin  is  not  licensed  for  the  treatment  of
ovine  mastitis;  therefore,  no  approved  breakpoints  are
vailable  for  the  classiﬁcation  of  bovine  staphylococcal  iso-
ates  from  mastitis  cases  as  susceptible  or  resistant.  The
IC  value  required  to  inhibit  90%  of  the  isolates  tested  was
eﬁned  as  MIC90.  Isolates  were  categorized  as  susceptible  or
esistant,  with  intermediates  classiﬁed  as  resistant.  Isolates
ith  a  MIC  for  oxacillin  >0.5  g/ml  were  additionally  exam-
ned  for  the  presence  of  the  mecA  gene  by  PCR  as  proposed
y  Mo  and  Wang14.
esults
istribution  of  CNS  species
wo  hundred  and  nineteen  CNS  isolates  from  cows  with
CM  were  identiﬁed  to  the  species  level  by  PCR-RFLP  of
he  groEL  gene.  The  distribution  of  different  species  among
dentiﬁed  CNS  is  shown  in  Table  1, where  S.  chromogenes
nd  S.  haemolyticus  were  the  predominant  species.  A  min-
mum  of  three  different  CNS  species  were  present  in  41.2%
f  the  herds.  S.  chromogenes  was  isolated  in  86.3%  of  all
arms,  whereas  S.  haemolyticus  was  isolated  in  66.7%  of
hem  (Table  1).
ntibiotic  susceptibility
n  the  present  study  219  CNS  isolated  from  cows  with  SCM
nd  identiﬁed  by  genotyping  were  evaluated  for  susceptibil-
ty  to  ﬁve  antimicrobials  (Table  2).  Penicillin  was  used  as  the
epresentative  of  penicillinase-labile  penicillins  and  is  the
ost  frequently  used  in  Argentina  for  bovine  mastitis  treat-
ent.  One  hundred  and  thirteen  strains  (51.6%)  of  the  219
trains  were  resistant  to  penicillin;  The  MIC90 value  for  this
ntibiotic  was  higher  than  8  g/ml,  well  above  the  recom-
ended  breakpoint.  Thirty  (13.7%)  of  all  CNS  isolates  tested
ere  resistant  to  oxacillin;  the  MIC90 value  for  this  antibi-
tic  was  0.5  g/ml.  Resistance  to  oxacillin  was  attributed
o  the  presence  of  the  mecA  gene  in  2  of  12  (16.7%)  of  the
xacillin-resistant  isolates  with  a  MIC  >0.5  g/ml.  Moderate
esistance  to  erythromycin  and  tetracycline  was  detected
mong  CNS  isolates,  29.2%  and  30.1%,  respectively.  In  our
tudy,  the  MIC90 values  of  erythromycin  and  tetracycline  for
NS  were  more  than  one  or  two  dilution  steps  higher  than
hose  of  the  recommended  breakpoint,  respectively.  Table  3
hows  phenotypic  resistance  proﬁles  of  CNS  obtained  from
ovine  SCM.  Of  219  CNS  isolates,  56  (25.6%)  were  phen-
typically  susceptible  to  all  antimicrobial  agents  tested.
ighty-ﬁve  (38.8%)  isolates  expressed  resistance  to  a  sin-
le  compound,  and  11  isolates  (5%)  expressed  resistance
o  2  related  compounds  (-lactams  antimicrobial  agents)
nd  67  (30.6%)  isolates  expressed  resistance  to  compounds
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Table  1  Species  distribution  of  coagulase-negative  staphylococci  (CNS)  isolates  from  bovine  subclinical  mastitis  in  51  Argen-
tinean dairy  herds
Species  No.  of  isolatesa CNS  IMIb (%)  No.  of  herdsc Distribution  of  each  CNS
species  in  dairy  herds
sampled  (%)
Staphylococcus  chromogenes  102  46.6  44  86.3
Staphylococcus  haemolyticus  70  32.0  34  66.7
Staphylococcus  warneri  16  7.3  14  27.5
Staphylococcus  xylosus  14  6.4  11  21.6
Staphylococcus  simulans  8  3.6  8  15.7
Staphylococcus  epidermidis 5  2.3 5  9.8
Staphylococcus  hyicus 4  1.8 4  7.8
Total 219  51
a Each organisms was isolated from only one cow (composite sample).
b IMI: intramammary infections.
c Number of dairy herds from which each species was isolated.
Table  2  Proportion  of  resistant  isolates  and  minimum  inhibitory  concentration  (MIC)  distribution  for  219  isolated  coagulase-
negative staphylococci  (CNS)  from  bovine  subclinical  mastitis
Antimicrobial 
agents
Number of CNS isolates for each MIC (µg/ml) values
Resistant 
isolates (%) 0.06 0.12 0.25 0.5 21 84 16 MIC50 MIC90
Penicillin 51.6 96 10 22 20 4 13 8 11 35 0.25 8>
Oxacillin 13.7 189 18 06 60 0.25 0.5
Erythromycin 29.2 83 72 [11] [4 ] [8] 41 0.5 > 4
Tetracycline 30.1 134 19 [8] 58 >2 16
Clindamycina NA 162 15 34 8 0.5 2>
White ﬁelds denote the range of dilutions tested for each substance. MICs above the range are given as the concentration closest to the
range. MICs equal to or lower than the lowest concentration tested are given as the lowest tested concentration. Bold vertical lines
indicate breakpoints based on veterinary interpretive criteria (CLSI 2008). Numbers in brackets indicate the number of isolates with a














Ca Clindamycin is not licensed for the treatment of bovine mastit
classiﬁcation of bovine staphylococcal isolates from mastitis case
belonging  to  different  antimicrobial  classes.  In  S.  chromo-
genes  and  S.  haemolyticus, the  most  prevalent  isolated
CNS  species,  a  large  proportion  of  the  strains  investigated
were  resistant  to  penicillin,  45.1%  and  58.6%,  respectively.
Although  resistance  to  oxacillin  was  lower  than  that  found  in
other  2  resistant  species  to  the  same  antibiotic,  the  number
of  isolates  of  these  species  was  too  low  to  draw  conclusions.
For  S.  warneri,  the  third  most  common  CNS  species,  the
proportion  of  resistant  isolates  to  penicillin  was  less  com-
mon  than  in  other  species  and  no  resistance  to  oxacillin  was
observed.  Finally,  in  S.  xylosus, penicillin  resistance  was  the
most  common  among  the  species  tested.  For  other  species,
S.  xylosus,  S.  epidermidis  and  S.  hyicus, the  number  of  resis-
tant  isolates  was  too  low  to  be  analyzed.  The  percentage
of  resistant  S.  haemolyticus  strains  to  two  or  more  non-
related  antimicrobials  was  higher  than  that  observed  in  S.




v a consequence, no approved breakpoints are available for the
usceptible or resistant; NA, not applicable.
iscussion
enotypic  methods  have  shown  to  have  higher  speciﬁcity
nd  sensitivity39 than  other  methods  for  discriminating
mong  species,  resulting  in  a  better  alternative  for  the
dentiﬁcation  of  CNS  isolates.  A  number  of  PCR  amplicon
equencing-based  methods  for  the  identiﬁcation  of  CNS
ave  been  reported5,26,30. Ampliﬁed  fragment  length  poly-
orphism  (AFLP)20,31 and  PCR-restriction  fragment  length
olymorphism  (RFLP)  applied  to  the  groEL  or  gap  genes
ave  been  used  to  identify  CNS  isolated  from  bovine
ilk15,25.  The  discrepancy  observed  in  the  distribution  of
NS  species  identiﬁed  by  genotyping  causing  SCM  in  differ-
nt  countries,  might  be  due  to  differences  in  experimental
esign10,20,30,31,35,38 however,  S.  chromogenes  was  one  of
he  most  prevalent  species  both  in  this  work  and  in  pre-
ious  studies  carried  out  in  other  countries  such  as  Finland,
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Table  3  Phenotypic  resistance  proﬁles  of  coagulase-negative  staphylococci  (CNS)  obtained  from  bovine  subclinical  mastitis
Species  Total  Phenotypic  resistance  to  antibioticsa
0  1  2  >2
P  O  E  T  PO  PT  PE  ET
Staphylococcus  chromogenes  102  25  13  2  17  12  8  10  3  0  3  POT,  3  POE,  6  PET
Staphylococcus  haemolyticus  70  18  14  1  7  0  0  12  3  3  5  POE,  7  PET
Staphylococcus  warneri  16  9  3  0  3  0  0  0  0  0  1  PET
Staphylococcus  xylosus  14  0  3  0  0  1  2  3  0  0  1  POT,  2  POE,  2  PET
Staphylococcus  simulans  8  2  6  0  0  0  0  0  0  0  --
Staphylococcus  epidermidis  5  0  0  0  1  1  1  0  0  0  2  POT
Staphylococcus  hyicus 4  2  0  0  0  1  0  0  0  1  --
Total 219  56  39  3  28  15  11  25  6  4  32
a When phenotypic resistance to 0, 1 or 2 compounds was observed, the number of isolates with the speciﬁed resistance proﬁle is












































































weden,  Belgium,  Canada  and  Brazil,  ranging  between  23.3%
nd  78.8%  of  CNS  isolates.  To  our  knowledge,  only  Piessens
t  al.20 revealed  that  S.  haemolyticus  was  the  second  most
revalent  CNS  species  as  in  our  study  causing  27.6%  of
ases.  Special  attention  should  be  given  to  both  species,
onsidering  that  the  udder  was  found  to  be  their  main
eservoir20.
In  our  study,  a  minimum  of  three  different  species  of  CNS
ere  present  in  41.2%  of  the  herds.  S.  chromogenes  and
.  haemolyticus  were  isolated  in  most  of  the  farms.  This  is
n  line  with  other  studies,  where  these  species  have  been
solated  from  all  analyzed  herds20,30.  Although  the  reasons
or  the  increased  prevalence  of  some  CNS  species  are  not
nown,  these  might  be  attributed  to  the  ability  of  each
pecies  to  adapt  to  the  mammary  gland10,20 or  to  the  dif-
erent  management  patterns  of  mastitis  control  schemes30.
One  limitation  to  the  present  study  is  the  fact  that  we
annot  be  sure  that  the  CNS  were  isolated  from  the  diseased
uarter  since  other  non-infectious  factors  could  cause  an
nﬂammatory  response.  However,  CNS  in  pure  culture  allow
o  ensure  that  they  are  the  only  etiological  agents  causing
ubclinical  mastitis.
The  direct  comparison  of  studies  on  antimicrobial  sus-
eptibility  of  CNS  is  often  difﬁcult  mainly  because  of  the
se  of  different  methodologies  and  breakpoints  for  testing
usceptibility.  A  great  variability  has  been  reported  in  the
IC90 values  for  penicillin  in  CNS,  ranging  from  0.12  g/ml  to
2  g/ml2,11,12,19,22,24,34.  The  MIC90 value  for  penicillin  found
n  our  study  was  well  above  the  recommended  breakpoint
CLSI,  2008).  Moreover,  the  penicillin  resistance  percent-
ge  was  higher  than  that  described  by  Gentilini  et  al.11
n  Argentina  and  those  reported  in  other  countries  such  as
ruguay12,  The  Netherlands27,  USA22 and  Sweden2. In  the
ast  decade,  Gentilini  et  al.11 reported  methicillin  resistance
mong  CNS  isolated  from  bovine  mastitis  in  our  country.
ince  continuous  surveillance  is  needed  for  the  early  detec-
ion  of  this  kind  of  resistance,  oxacillin  has  been  used  in
his  study  to  test  susceptibility  to  methicillin.  The  MIC90
alue  for  oxacillin  was  similar  to  those  reported  by  different
uthors11--13,24,28.  The  percentage  of  resistant  strains  found




aimilar  to  that  reported  in  studies  from  Finland,  Germany,
SA,  Sweden  and  The  Netherlands19,21,22,27,28.  The  variability
n  the  MIC90 values  of  the  antimicrobial  activity  of  peni-
illin  and  oxacillin  against  CNS  highlights  the  relevance  of
etermining  -lactams  susceptibility  patterns  for  this  bac-
erial  group.  Macrolides  are  frequently  used  in  Argentina  for
ovine  mastitis  treatment,  since  high  concentrations  in  milk
re  obtained  following  parenteral  administration.  Although
rythromycin  was  evaluated  as  representative  of  this  group,
ylosin  is  used  in  the  therapy.  Tetracycline  was  included
n  this  study  for  epidemiological  purposes  as  representa-
ive  of  tetracyclines;  however,  they  are  not  recommended
or  mastitis  treatment  in  Argentina  because  of  the  risk
f  an  extended  residue  presence  in  milk.  The  MIC90 value
or  erythromycin  and  tetracycline  was  higher  than  that
bserved  by  several  authors  in  Argentina,  Finland,  Ger-
any,  Sweden  and  USA2,11,13,19,21,28.  Although  clindamycin  is
ot  used  in  the  treatment  of  bovine  mastitis,  the  deter-
ination  of  the  MIC  for  this  antibiotic  was  conducted  in
rder  to  test  susceptibility  to  lincomycin;  however,  spe-
iﬁc  interpretative  breakpoints  are  deﬁned  for  pirlimicyn6.
usceptibility  to  pirlimycin  could  not  be  inferred  from
lindamycin  results  because  some  mechanism  (enzymatic
odiﬁcation)  does  not  exhibit  cross-resistance.  The  MIC90
alue  for  clindamycin  obtained  in  this  study  was  similar  to
hat  previously  described  by  Gentilini  et  al.11 in  our  coun-
ry  and  higher  than  that  reported  by  other  investigators  in
ifferent  countries2,13,19,21. The  proportion  of  CNS  resistant
o  a single  compound  or  two  related  compounds  obtained
n  our  study  was  found  to  be  similar  to  that  described  by
ampimon  et  al.27S.  haemolyticus  and  S.  chromogenes  were
he  most  frequent  resistant  species;  therefore,  it  would
lso  be  hypothesized  that  they  should  be  more  ‘‘at  risk’’
f  developing  antibiotic  resistance  or  acquiring  resistance
eterminants.  Conversely,  the  absence  or  lower  percentages
f  resistant  isolates  to  multiple  drugs  for  both  species  were
ound  by  Sampimon  et  al.27 We  conclude  that  CNS  species
rom  bovine  subclinical  mastitis  differ  in  prevalence  and
ntimicrobial  resistance  proﬁles,  which  may  have  implica-
ions  for  treatment  and  management  decisions  when  CNS















2CNS:  Prevalence  and  antibiotic  susceptibility  
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